BEIJING, Dec. 22, 2025 /PRNewswire/ -- When disruptive changes redefined market demand in the past days of 2025, Chinese baijiu producer…
SAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…
LONDON, Dec. 17, 2025 /PRNewswire/ -- UK-based education multinational GEDU Global Education has signed an agreement with the United Nations Institute…
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2025 – Genmab…
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…
26 November 2025 - The International Olympic Committee (IOC) Executive Board (EB) will hold its final meeting of 2025 on 9 and…
Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN)BPDCN…